Inhaled Drug Delivery 2018 by Management Forum
In-Person Event
Nov 01 - 02, 2018
London, England, GB
OVERVIEW
Inhaled Drug Delivery is organized by Management Forum (Mf) Ltd and will be held from Nov 01 - 02, 2018 at The Rembrandt Hotel, London, England, United Kingdom.
Conference Overview:
Inhaled drug delivery is achieved using four principle technologies, dry powder inhalers, metered dose inhalers, nebulizers and liquid inhalers. Although there are many differences between these technologies there are many fundamental principles that are followed to achieve an effective delivered dose, as such there is much shared learning across the technologies.
This meeting includes presentations on each of these delivery technologies with the intent to share knowledge and learning across the inhaled drug development business. The future European and UK regulatory processes following Brexit will be critical when developing product approval strategies, we shall be considering regulatory issues on this and other important hot topics.
There are a number of key areas that are currently evolving and the latest thinking and progress on these will be presented, including Human factor design and sensing/connecting technologies. These key evolving areas are subject to much debate and require careful consideration whilst developing an inhaled drug product.
Program To Include:
• Modern respiratory medicines
• Innovation in nebulized therapy
• Current and future trends for DPI formulation
• Opportunities of nanoformulations in the lung
• The role of lung protease in delivery of inhaled biopharmaceuticals
• Lung deposition software: Mimetikos preludium: a new pharma friendly aerosol drug deposition calculator
• Could smart inhalers dramatically change the way that Asthma and COPD patients are treated? n Decoding FDA’s recent combination drug product guidance: Applications to DPIs, pMDIs, and nasal sprays
• The UK regulatory future - the way forward after Brexit
• Navigating human factors in device development
• The 1nhaler and its two jobs
• Opportunities and challenges in the design of high-performance unit-dose dry powder inhalers n Design characterization of breath actuation mechanisms
• Digitally enabled inhalers
Reasons to Attend:
• A valuable update on the advances in inhalation technology and inhaled drug delivery
• An opportunity to keep abreast of trends in the market
• The chance to develop business relationships
Tickets :
• Course Fee in GBP 1299.00 book before Aug 24, 2018, after that GBP 1499.00 upto Nov 01, 2018.
• Course Fee in EUR 1819.00 book before Aug 24, 2018, after that EUR 2099.00 upto Nov 01, 2018.
Additional details will be posted as soon as they are available.
Conference Overview:
Inhaled drug delivery is achieved using four principle technologies, dry powder inhalers, metered dose inhalers, nebulizers and liquid inhalers. Although there are many differences between these technologies there are many fundamental principles that are followed to achieve an effective delivered dose, as such there is much shared learning across the technologies.
This meeting includes presentations on each of these delivery technologies with the intent to share knowledge and learning across the inhaled drug development business. The future European and UK regulatory processes following Brexit will be critical when developing product approval strategies, we shall be considering regulatory issues on this and other important hot topics.
There are a number of key areas that are currently evolving and the latest thinking and progress on these will be presented, including Human factor design and sensing/connecting technologies. These key evolving areas are subject to much debate and require careful consideration whilst developing an inhaled drug product.
Program To Include:
• Modern respiratory medicines
• Innovation in nebulized therapy
• Current and future trends for DPI formulation
• Opportunities of nanoformulations in the lung
• The role of lung protease in delivery of inhaled biopharmaceuticals
• Lung deposition software: Mimetikos preludium: a new pharma friendly aerosol drug deposition calculator
• Could smart inhalers dramatically change the way that Asthma and COPD patients are treated? n Decoding FDA’s recent combination drug product guidance: Applications to DPIs, pMDIs, and nasal sprays
• The UK regulatory future - the way forward after Brexit
• Navigating human factors in device development
• The 1nhaler and its two jobs
• Opportunities and challenges in the design of high-performance unit-dose dry powder inhalers n Design characterization of breath actuation mechanisms
• Digitally enabled inhalers
Reasons to Attend:
• A valuable update on the advances in inhalation technology and inhaled drug delivery
• An opportunity to keep abreast of trends in the market
• The chance to develop business relationships
Tickets :
• Course Fee in GBP 1299.00 book before Aug 24, 2018, after that GBP 1499.00 upto Nov 01, 2018.
• Course Fee in EUR 1819.00 book before Aug 24, 2018, after that EUR 2099.00 upto Nov 01, 2018.
Additional details will be posted as soon as they are available.
KEY DATES
01 Nov, 2018
Event Start Date
02 Nov, 2018
Event End Date
SPECIALITIES
Pharmacy and MedicineSUGGESTED HOTELS
CONFERENCE VENUE
The Rembrandt HotelRELATED CONFERENCES & LIVE WEBINARS
Quick Links